Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs-Reference-Cited by-同舟云学术

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

Published:2013-02-14 Issue:5 Volume:108 Page:1071-1078
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

van Leeuwen R W F,Brundel D H S,Neef C,van Gelder T,Mathijssen R H J,Burger D M,Jansman F G A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201348.pdf

Reference45 articles.

1. Drug Interaction Facts Version 4.0. (2006) Wolters Kluwer Health. Available at: http://www.factsandcomparisons.com (Last consulted on 16 January 2013)

2. Scientific Advisory Board of the Arizona Center for Education and Research on Therapeutics (CERT). QT Drug Lists Available at: http://www.arizonacert.org 2(Last consulted on 16 January 2013)

3. Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health Syst Pharm 64 (suppl 5): S4–S7

4. Barrons R (2004) Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 61: 380–385

5. Bourré-Tessier J, Haraoui B (2010) Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 37: 1416–1421

Cited by 189 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2‐Deoxyglucose and hydroxychloroquine HPLC‐MS–MS analytical methods and pharmacokinetic interactions after oral co‐administration in male rats;Pharmacology Research & Perspectives;2024-01-31

2. Concordance analysis of two databases to search for potential drug interactions in onco-hematologic patients;Journal of Oncology Pharmacy Practice;2024-01-30

3. Potential drug–drug interaction and its determinants among patients with cancer receiving chemotherapy in oncology centres of Northwest Ethiopia: an institutional-based cross-sectional study;BMJ Open;2023-12

4. The value of pharmaceutical expertise in the detection and management of drug interactions with targeted therapies in melanoma;Annales de Dermatologie et de Vénéréologie;2023-12

5. Impact of Medication Reconciliation in Oncology Early Phase Studies: A Drug-Drug Interaction Retrospective Study;JCO Oncology Practice;2023-11-09